Atlas Trials

Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia

Clinical trial NCT00588146 · TERMINATED

Trial details

NCT number
NCT00588146
Sponsor
Mayo Clinic
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
AnemiaLiver DiseaseHypoxemia
Start date
2007-01-01
Primary completion
2011-09-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.